Our study demonstrated the potential use of WSQL in BPH therapy and other types of BPH research and supported that the modulation of Nrf2 and NF-κB pathways has favorable therapeutic effects in improving BPH. This evidence concerns the gene NFKB1 and benign prostatic hyperplasia.